NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease
Bronchodilation with a long-acting muscarinic antagonist (LAMA) or long-acting β 2 -agonist is central to the management of chronic obstructive pulmonary disease (COPD). Tiotropium, the first LAMA available for use in COPD, has been shown to be an effective bronchodilator and is generally safe and w...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2011-06-01
|
| Series: | Therapeutic Advances in Respiratory Disease |
| Online Access: | https://doi.org/10.1177/1753465811406001 |